SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-24-008788
Filing Date
2024-02-21
Accepted
2024-02-21 16:15:33
Documents
1
Group Members
BENJAMIN ROVINSKIDANIEL HETUGERALD BRUNKJACKI JENUTHLUMIRA CAPITAL GP, L.P.LUMIRA GP HOLDINGS CO.LUMIRA GP INC.LUMIRA III GP HOLDINGS CO.LUMIRA III GP INC.LUMIRA IV GP 2020 INC.LUMIRA VENTURES III (INTERNATIONAL), L.P.LUMIRA VENTURES III GP, L.P.LUMIRA VE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ef20022031_sc13da.htm SC 13D/A 698894
  Complete submission text file 0001140361-24-008788.txt   701290
Mailing Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5
Business Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5 416-213-4223
Lumira Capital Investment Management Inc. (Filed by) CIK: 0001702636 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Subject) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-94211 | Film No.: 24659646
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)